GelTex Pharmaceuticals

About:

GelTex Pharmaceuticals develops and markets non-absorbed polymer drugs.

Top Investors: Norwest Venture Partners, New Enterprise Associates, SV Health Investors, Abingworth, Domain Associates

Description:

GelTex Pharmaceuticals develops and markets non-absorbed polymer drugs that bind and eliminate targeted substances within the gastrointestinal tract. It also develops small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators. Its focus areas include hyperphosphatemia, hypercholesterolemia, cancer, iron overload, and infectious diseases. GelTex Pharmaceutics is based in Waltham Massachusetts.